Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque posuere mi id ante ultricies sit amet adipiscing lectus tincidunt. Morbi tortor libero, fringilla id pharetra at, sollicitudin id nibh. Maecenas in ullamcorper lectus. Fusce tristique condimentum eleifend. Fusce pellentesque risus eu tortor feugiat dignissim bibendum leo tempus. Sed sedrisus non dolor commodo commodo vitae sed ante.
- In: What We Do
- Hits: 4299
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque posuere mi id ante ultricies sit amet adipiscing lectus tincidunt. Morbi tortor libero, fringilla id pharetra at, sollicitudin id nibh. Maecenas in ullamcorper lectus. Fusce tristique condimentum eleifend. Fusce pellentesque risus eu tortor feugiat dignissim bibendum leo tempus. Sed sedrisus non dolor commodo commodo vitae sed ante.
- In: What We Do
- Hits: 2055
“Life sciences refer to the scientific study of the living world as a whole. It's a new synthesis of several traditional disciplines, including biology, zoology and botany with newer, more specialized areas of study, such as biosciences, biochemistry, biotechnology, bio-informatics, genetics, pharmaceutical studies, food science and technology and environmental science.
- In: What We Do
- Hits: 4004
ImmuneVax consulting has access to a large and comprehensive network of highly trained, skilled and accomplished experts covering the whole world. We have the potential to selectively create project teams to cater for your specific needs.
ImmuneVax offers a broad range of consulting services that can range from short-term assistance, through mentoring to comprehensive project management consulting and deep engagement.
- In: What We Do
- Hits: 4016
As global competitive pressure accelerates and regulatory oversight increases, life sciences companies today face an unprecedented need to proactively manage research and licensing due diligence, protect business assets and increase revenue. In fact, most life sciences companies today look at in- and out-licensing of their intellectual property as an essential component of their growth strategy.
- In: What We Do
- Hits: 1773
Venture creation is not a linear process; rather, it is driven by social networks, serendipitous meetings and flashes of insight. Much of the progress in the prevention, diagnosis, and treatment of disease can be attributed to medical research in university labs.
Not surprisingly, turning ideas into business ventures is tricky. A key ingredient in successful entrepreneurship is self-knowledge. If entrepreneurs know their limitations and strengths, they may be able to avoid some common pitfalls in starting up a biotech company.
- In: What We Do
- Hits: 4322
Life Science innovation is critical to growth and socio-economic development as “healthy people produce healthy economies”. Our Life Science business development provides incubation and added value to technologies, products, and services. ImmuneVax has access to numerous state-of-the art wet labs, clean rooms, cell culture facilities, and office space, designed for housing R&D driven companies.
- In: What We Do
- Hits: 1826
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque posuere mi id ante ultricies sit amet adipiscing lectus tincidunt. Morbi tortor libero, fringilla id pharetra at, sollicitudin id nibh. Maecenas in ullamcorper lectus. Fusce tristique condimentum eleifend. Fusce pellentesque risus eu tortor feugiat dignissim bibendum leo tempus. Sed sedrisus non dolor commodo commodo vitae sed ante.
- In: What We Do
- Hits: 2053
ImmuneVax prides itself in making the right choices when it comes to investment opportunities.
We make full use of our all encompassing global expertise-base to conduct the most stringent due diligence to immediately eliminate non-viable opportunities, yet positioning ourselves to rapidly add value to and plot the growth path for the select and most robust growth opportunities.
- In: What We Do
- Hits: 2108
A strong intellectual property portfolio is of enormous value to life science companies since much of their value is derived from the intellectual property rights, particularly patents, they possess. That is, the cornerstone of a life science company is its intellectual property. A life science company that cannot demonstrate the ability to bring its technology or products to market will find it very difficult to raise venture capital.
- In: What We Do
- Hits: 1876
Joint ventures and alliances serve many purposes, including filling gaps in capabilities, facilitating new market entry or sharing risks.
Several trends drive the value of these partnerships, including shortened product life cycles, globalization of competition and increased specialization of skills and capabilities.
- In: What We Do
- Hits: 1998
Strategic communications and marketing play critical roles in today's existing and emerging industry segments including; life sciences, medical technologies and devices, biotech, diagnostics, medical equipment, and pharmaceuticals. ImmuneVax provides marketing strategy for life science, biotech and medical device companies. We drive sales and market share. We increase our client's connections with their customers using rational strategies to communicate complex messages to sophisticated audiences.
- In: What We Do
- Hits: 2123
